TOPCAL TREATMENT OF EYE SURFACE NFLAMMATION AND RELATED DRY EYE DISEASE

Medline Abstract 76133934-Massey et al., 1976. * Huber-Spitzy, V. et al., “Treatment of ocular chlamydial infection: Comparison of tetracyclines and norfloxacin,” Ophthalmologica, 205(2):64–68 (1992). Salamon, S.M. “Tetracyclines in ophthalmology, Survey of Ophthalmology 29(4):265–75 (1985). Scott, C.A. et al., “Optometric clinical practice guideline care of the patient with ocular Surface disease, Ocular Surface Disease, pp. 1-33 (1999), http://www.aoanet. org/ cpg-10-cpoSd.html. Van Gogh, E.R. et al., “Topical antibiotics in ophthalmol ogy. ” Pharmaceutisch Weekblad, 129:156–163 (1994). Bartholomew, R.S. et al. “Oxytetracycline in the Treatment of Ocular Rosacea: a Double-blind Trial' British Journal of Ophthalmology 66:386-388 (1982). Belsheim, J. et al. “Tetracyclines and Host Defense Mecha nisms: Interference with Leukocyte Chemotaxis' Scand. J. Infect. Dis. 11:141-145 (1979). Bowman, R.W. et al. “Diagnosis and Treatment of Chronic Blepharitis” vol. VII Module 10, Focal Points 1989: Clini cal Modules for Ophthalmologists American Academy of Ophthalmology, San Francisco (1989). Brown, S.I. and Shahinian, L. Jr. “Biagnosis and Treatment of Ocular Rosacea” Ophthalmol. 85:779-786 (1978). Dilly, P.N. and Mackie, I.A. “Distribution of Tetracycline in the Conjunctiva of Patients on Long Term Systemic Doses” British Journal of Ophthalmology 69:25–28 (1985). Elewski, B.E. et al. “In Vivo Suppression of Neutrophil Chemotaxis by Ststemically and Topically Administered Tetracycline” Journal of the American Academy of Derma tology 8(6):807-812 (1983). Esterly, N.B. et al. “Neutrophil Chemotaxis in patients With Acne Receiving Oral Tetracycline Therapy” Arch. Derma tol. 120:1308–1313 (1984). Forsgren, A. et al. “Effect of Tetracycline on the Phagocytic Function of Human Leukocytes' The Journal of Infectious Diseases 130(4):412–415 (1974). Friend, J. et al. “Glycogen and DNA Content of Corneal Epithelium: Comparison of Preparation Methods” Invest. Ophthalmol. Vis. Sci. 24:203-207 (1983). Gilbard, J.P. and Rossi, S.R. “An Electrolyte-based Solution that Increases Corneal Glycogen and Conjunctival Goblet cell Density in a Rabbit Model for Keratoconjunctivitis sicca " Ophthalmology 99:600-604 (1992). Gilbard, J.P. et al. “A New Rabbit Model For KeratocOn junctivitis Sicca' Invest. Ophthalmol. Vis. Sci. 28:225-228 (1987). Gilbard, J.P. et al. “Ophthalmic Solutions, the Ocular Sur face, and a Unique Therapeutic Artificial Tear Formation” American Journal of Ophthalmology 107:348-355 (1989). Gilbard, J.P. et al. “Tear Film and Ocular Surface Changes after Closure of the Meibomian Gland Orifices in the Rabbit” Ophthalmology 96:1180–1186 (1989). Gilbard, J.P. et al. “Tear Film Osmolarity and Ocular Surface Disease in Two Rabbit Models For Keratoconjunctivitis sicca" Invest. Ophthalmol. Vis. Sci. 29:374–378 (1988). Golub, L.M. et al. “Further Evidence that Tetracyclines Inhibit Collagenase Activity in Human Crevicular Fluid and From Outer Mammalian Sources” Journal of Periodontal Research 20:12–23 (1985). Golub, L.M. et al. “Minocyline Reduces Gingival Col lagenolytic Activity During Diabetes’ Journal of Periodo natal Research 18:516–526 (1983). Golub, L.M. et al. “Tetracyclines Inhibit Tissue Collagenase Activity” Journal of Periodontal Research 19:651–655 (1984). Gutgesell, V.J. et al. “Histopathology of Meibomian gland Dysfunction American Journal of Ophthalmology 94:383–387 (1982). Hoeprich, P.D. and Warshauer, D.M. “Entry of Four Tetra cyclines into Saliva and Tears' Antimicrobial Agents and Chemotherapy 5(3):330–356 (1974).